Pregabalin (Reformulation)
Product Description
Medis ehf.
-
Country/Region:Iceland
-
On CPHI since:2015
-
Certificates:2
-
Employees:100 - 249
Company types
Primary activities
Categories
Specifications
Medis ehf.
-
Country/Region:Iceland
-
On CPHI since:2015
-
Certificates:2
-
Employees:100 - 249
Company types
Primary activities
More Products from Medis ehf. (26)
-
Product Lisdexamfetamine (Commercial)
A broad-strength capsule opportunity associated with attention deficit hyperactivity disorder.
Dosage form: Hard capsule Strengths: 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg Therapeutic area: Nervous system Key indication: Attention deficit hyperactivity disorde... -
Product Lisinopril (Reformulation)
A six-strength ACE-inhibitor opportunity undergoing reformulation.
Dosage form: Film-coated tablet Strengths: 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg Therapeutic area: Cardiovascular Key indication: Hypertension Product class: ACE inhibitor Expected d... -
Product Losartan (Reformulation)
A four-strength angiotensin II receptor blocker opportunity undergoing reformulation.
Dosage form: Film-coated tablet Strengths: 12.5 mg, 25 mg, 50 mg and 100 mg Therapeutic area: Cardiovascular Key indication: Hypertension Product class: Angiotensin II re... -
Product Melatonin (Commercial)
A prolonged-release oral product associated with circadian-rhythm sleep disorders.
Dosage form: Prolonged-release tablet Strength: 2 mg Therapeutic area: Nervous system Key indication: Circadian-rhythm sleep disorders Product class: Hypnotic and sedative a... -
Product Out-licensing
Medis is an established provider of dossiers and products in all areas of the world with launches and marketing authorizations in over 140 countries to date. -
Product Palbociclib (Pipeline)
An oral pipeline opportunity associated with the treatment of breast cancer.
Dosage form: Film-coated tablet Strengths: 75 mg, 100 mg and 125 mg Therapeutic area: Antineoplastic and immunomodulating agents Key indication: Breast cancer Product class:... -
Product Ruxolitinib (Pipeline)
A multi-strength hematology pipeline opportunity associated with myelofibrosis.
Dosage form: Tablet Strengths: 5 mg, 10 mg, 15 mg, 20 mg and 25 mg Therapeutic area: Antineoplastic and immunomodulating agents Key indication: Myelofibrosis Product clas... -
Product Trametinib (Pipeline)
A targeted-oncology pipeline opportunity associated with metastatic melanoma.
Dosage form: Film-coated tablet Strengths: 0.5 mg and 2 mg Therapeutic area: Antineoplastic and immunomodulating agents Key indication: Metastatic melanoma Product class: P... -
Product Alprazolam (Reformulation)
A four-strength anxiolytic tablet portfolio undergoing reformulation.
Dosage form: Tablet Strengths: 0.25 mg, 0.5 mg, 1 mg and 2 mg Therapeutic area: Nervous system Key indication: Anxiety Product class: Anxiolytic Dossier status: Available Estimated CPP timi... -
Product Amlodipine / Indapamide / Perindopril Arginine (Commercial)
A three-component fixed-dose combination opportunity for partners seeking to expand their cardiovascular portfolio.
Dosage form: Film-coated tablet Strengths: 5 mg/1.25 mg/5 mg, 5 mg/2.5 mg/10 mg, 10 mg/1.25 mg/5 mg and 10 mg/2.5 mg/10 mg Therapeutic area: Cardiovas... -
Product Apremilast (Commercial)
An oral product opportunity associated with immune-mediated conditions, including plaque psoriasis and psoriatic arthritis.
Dosage form: Film-coated tablet Strengths: 10 mg, 20 mg and 30 mg Therapeutic area: Antineoplastic and immunomodulating agents Key ind... -
Product Atenolol (Reformulation)
A three-strength beta-blocker opportunity undergoing reformulation.
Dosage form: Tablet Strengths: 25 mg, 50 mg and 100 mg Therapeutic area: Cardiovascular Key indication: Hypertension Product class: Beta-blocking agent Dossier status: Available The three-...
Medis ehf. resources (2)
-
Video Medis Now - Online Customer Portal explainer
A short explainer video introducing Medis now, our online customer portal which gives our customers access to valuable information, insights and ordering capabilities 24/7. -
Video A short introduction to Medis
A short video introduction to Medis, where you can find out all the basic information about the company and how it operates and in which markets.